Cargando…
Elcatonin attenuates disuse osteoporosis after fracture fixation of tubular bone in rats
BACKGROUND: Elcatonin (ECT) is used to prevent and treat osteoporosis. However, little is known about its effect on the disuse osteoporosis (DOP). The aim of this study is to evaluate the effect of ECT on DOP caused by fracture fixation. METHODS: Forty-five male Sprague-Dawley (SD) rats, aged 6 week...
Autores principales: | Ji, Zhe, Shi, Chao, Huang, Shengli, Dang, Xiaoqian, Wang, Kunzheng, Lan, Binshang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499200/ https://www.ncbi.nlm.nih.gov/pubmed/26138716 http://dx.doi.org/10.1186/s13018-015-0246-0 |
Ejemplares similares
-
Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures
por: Wang, Baohui, et al.
Publicado: (2022) -
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009) -
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
por: Okamoto, Hiroaki, et al.
Publicado: (2020) -
Disuse Osteoporosis: Clinical and Mechanistic Insights
por: Rolvien, Tim, et al.
Publicado: (2021) -
A Review on Current Osteoporosis Research: With Special Focus on Disuse Bone Loss
por: Lau, Roy Yuen-chi, et al.
Publicado: (2011)